Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry-Reference-Cited by-同舟云学术

Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry

Published:2011-11 Issue:11 Volume:17 Page:1638-1645
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Cook Gordon,Liakopoulou Effie,Pearce Rachel,Cavet Jim,Morgan Gareth J.,Kirkland Keiren,Lee Julia,Davies Faith E.,Hall Rachel,Rahemtulla Amin,Russell Nigel,Marks David I.

Funder

Leukaemia Lymphoma Research

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Survival from multiple myeloma in England and Wales up to 2001;Schey;Br J Cancer,2008

2. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321;Barlogie;J Clin Oncol,2006

3. High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution;Blade;Bone Marrow Transplant,2000

4. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

5. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study;HemaSphere;2024-07-29

2. The efficacy and safety of second salvage autologous transplantation in myeloma patients;Pathology and Oncology Research;2024-07-16

3. Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience;Bone Marrow Transplantation;2023-07-21

4. Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis;Indian Journal of Cancer;2023

5. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT;Bone Marrow Transplantation;2022-02-15